Evidence map›Paper›PMID 25496218›Full record

ArticleACS chemical neuroscience2015

Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1.

Courtney D Prince, Andrew R Rau, Jordan T Yorgason, Rodrigo A España

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 86 citations in OpenAlex.

  1. Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Review
  3. Hypocretin receptor 1 blockade early in abstinence prevents incubation of cocaine seeking and normalizes dopamine transmission.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Sleep-mediated regulation of reward circuits: implications in substance use disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  18. Individual differences in dopamine uptake in the dorsomedial striatum prior to cocaine exposure predict motivation for cocaine in male rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Courtney D PrinceDepartment of Neurobiology and Anatomy, Drexel University College of Medicine , Philadelphia, Pennsylvania 19129, United States.
Andrew R Rau
Jordan T Yorgason
Rodrigo A España
Drexel University · USVollum Institute · USWake Forest University · US

Funding

BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
Involvement of hypocretin-orexin in the regulation of dopamine signaling and reinforcement processes in femalesR01DA031900 · NIDA · DREXEL UNIVERSITY · PI ESPAÑA, RODRIGO A. · 2013 to 2022
$3.6M
Hypocretin/Orexin Modulation of Reward and Addiction ProcessesK01DA025279 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPAÑA, RODRIGO A. · 2008 to 2012
$771k
Cocaine Enhances Spontaneous Dopamine Release by Increasing Cholinergic ActivityF32DA040409 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI YORGASON, JORDAN THOMAS · 2015 to 2015
$52k
NIDA NIH HHS F32 DA040409NIDA NIH HHS K01DA025279NIDA NIH HHS R01 DA031900NIDA NIH HHS R01DA031900NIDA NIH HHS T32 DA007262NIDA NIH HHS T32DA007262
6 · The paper itself

Abstract

Extensive evidence suggests that the hypocretins/orexins influence cocaine reinforcement and dopamine signaling via actions at hypocretin receptor 1. By comparison, the involvement of hypocretin receptor 2 in reward and reinforcement processes has received relatively little attention. Thus, although there is some evidence that hypocretin receptor 2 regulates intake of some drugs of abuse, it is currently unclear to what extent hypocretin receptor 2 participates in the regulation of dopamine signaling or cocaine self-administration, particularly under high effort conditions. To address this, we examined the effects of hypocretin receptor 1, and/or hypocretin receptor 2 blockade on dopamine signaling and cocaine reinforcement. We used in vivo fast scan cyclic voltammetry to test the effects of hypocretin antagonists on dopamine signaling in the nucleus accumbens core and a progressive ratio schedule to examine the effects of these antagonists on cocaine self-administration. Results demonstrate that blockade of either hypocretin receptor 1 or both hypocretin receptor 1 and 2 significantly reduces the effects of cocaine on dopamine signaling and decreases the motivation to take cocaine. In contrast, blockade of hypocretin receptor 2 alone had no significant effects on dopamine signaling or self-administration. These findings suggest a differential involvement of the two hypocretin receptors, with hypocretin receptor 1 appearing to be more involved than hypocretin receptor 2 in the regulation of dopamine signaling and cocaine self-administration. When considered with the existing literature, these data support the hypothesis that hypocretins exert a permissive influence on dopamine signaling and motivated behavior via preferential actions on hypocretin receptor 1.

Indexed as

Analysis of VarianceAnimalsBenzoxazolesCocaineDopamineDopamine Uptake InhibitorsDose-Response Relationship, DrugElectrochemical TechniquesIntracellular Signaling Peptides and ProteinsMaleNaphthyridinesNeuropeptidesOrexin Receptor AntagonistsOrexin ReceptorsOrexinsRats1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl ureaBenzoxazolesCocaineDopamineDopamine Uptake InhibitorsHcrtr1 protein, ratIntracellular Signaling Peptides and ProteinsNaphthyridinesNeuropeptidesOrexin Receptor AntagonistsOrexin ReceptorsOrexinsUreaAddictiondrug abusefast scan cyclic voltammetrymotivationreward

Identifiers

PMID25496218
PMCPMC4304483
OpenAlexW2081264391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.